COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,550 Articles (22,881 medRxiv, 8,669 bioRxiv)

Most recent first Previous |  Page 1241: Articles 12401-12410  | Next

A virus-specific monocyte inflammatory phenotype is induced by SARS-CoV2 at the immune-epithelial interface
Leon, J., Michelson, D. A., Olejnik, J., Chowdhary, K., Oh, H. S., Hume, A. J., Galvan-Pena, S., Zhu, Y., Chen, F., Vijaykumar, B., Yang, L., Crestani, E., Yonker, L. M., Knipe, D. M., Muhlberger, E., Benoist, C.
10.1101/2021.09.29.462202 — Posted: 2021-09-29
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Torres, J. L., Ozorowski, G., Andreano, E., Liu, H., Copps, J., Piccini, G., Donnici, L., Conti, M., Planchais, C., Planas, D., Manganaro, N., Pantano, E., Paciello, I., Pileri, P., Bruel, T., Montomoli, E., Mouquet, H., Schwartz, O., Sala, C., De Francesco, R., Wilson, I. A., Rapuoli, R., Ward, A. B.
10.1101/2021.09.28.462234 — Posted: 2021-09-29
Initial Analysis of Viral Dynamics and Circulating Viral Variants During the mRNA-1273 Phase 3 COVE Trial
Pajon, R., Paila, Y., Girard, B., Dixon, G., Kacena, K., Baden, L. R., El Sahly, H. M., Essink, B., Mullane, K. M., Frank, I., Denham, D., Kerwin, E., Zhao, X., Ding, B., Deng, W., Tomassini, J., Zhou, H., Leav, B., Schodel, F.
10.1101/2021.09.28.21264252 — Posted: 2021-09-29 Discussion: Onsite
A brief analysis of the COVID-19 death data in Malaysia
Arifin, W. N., Musa, K. I., Hanis, T. M., Rodzlan Hasani, W. S., Che Nawi, C. M. N. H., Ershad Ahmad Khan, E., Suliman, M. A., Termizi, S. A., Ab Aziz, W. A.
10.1101/2021.09.28.21264234 — Posted: 2021-09-29
Contribution of Schools to Covid-19 Pandemic: Evidence from Czechia
Smid, M., Zajicek, M., Brom, C., Drbohlav, J.
10.1101/2021.09.28.21264244 — Posted: 2021-09-29
Excess Deaths associated with the COVID-19 Pandemic in Ukraine in 2020
Mehta, N., Honchar, I., Doroshenko, O., Brovenchko, I., Pak, K., Danyuk, M., Polikarchuk, P.
10.1101/2021.09.28.21264266 — Posted: 2021-09-29 Discussion: Onsite
Mucosal antibody response to SARS-CoV-2 in paediatric and adult patients: a longitudinal study
Chan, R., Chan, K. C., Lui, G. C., Tsun, J. G., Chan, K. Y., Yip, J. S., Liu, S., Yu, M. W., Ng, R. W., Chong, K. K., Wang, M. H., Chan, P. K., Li, A. M., Lam, H. S.
10.1101/2021.09.27.21264219 — Posted: 2021-09-29
Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients
Tsuzuki, S., Miyazato, Y., Terada, M., Morioka, S., Ohmagari, N., Beutels, P.
10.1101/2021.09.27.21264225 — Posted: 2021-09-29
SARS-CoV-2 nucleocaspid antigen in urine of hospitalized patients with Covid-19
Veyrenche, N., Pisoni, A., Debiesse, S., Bollore, K., Bedin, A.-S., Makinson, A., Mondain, A.-M., Le Moing, V., Van de Perre, P., Tuaillon, E.
10.1101/2021.09.28.21264239 — Posted: 2021-09-29
A MUC5B gene polymorphism, rs35705950-T, confers protective effects in COVID-19 infection
Verma, A., Minnier, J., Huffman, J. E., Wan, E. S., Gao, L., Joseph, J., Ho, Y.-L., Wu, W.-C., Cho, K., Gorman, B. R., Rajeevan, N., Pyarajan, S., Garcon, H., Meigs, J. B., Sun, Y. V., Reaven, P. D., McGeary, J. E., Suzuki, A., Gelernter, J., Lynch, J. A., Petersen, J. M., Zekavat, S. M., Natarajan, P., Madison, C. J., Dalal, S., Jhala, D. N., Arjomandi, M., Gatsby, E., Lynch, K. E., Bonomo, R. A., Freiberg, M., Pathak, G. A., Zhou, J. J., Donskey, C. J., Madduri, R. K., Wells, Q. S., Huang, R. D., Polimanti, R., Chang, K.-M., Liao, K. P., Tsao, P. S., Wilson, P. W. F., O'Donnell, C. J., Gaziano, J. M., Hauger, R. L., Iyengar, S. K., Luoh, S.-W.
10.1101/2021.09.28.21263911 — Posted: 2021-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).